Search

Your search keyword '"A Kruse, Torben"' showing total 1,041 results

Search Constraints

Start Over You searched for: Author "A Kruse, Torben" Remove constraint Author: "A Kruse, Torben"
1,041 results on '"A Kruse, Torben"'

Search Results

1. Male with an apparently normal phenotype carrying a BRCA1 exon 20 duplication in trans to a BRCA1 frameshift variant

2. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

4. Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses

6. The CHIP-clinic as the catalyst of preventive medicine.

7. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.

12. Ensemble‐based classification using microRNA expression identifies a breast cancer patient subgroup with an ultralow long‐term risk of metastases.

13. Insight into spatial intratumoral genomic evolution in glioblastoma

15. CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3

21. Generalized Correlation Coefficient for Non-Parametric Analysis of Microarray Time-Course Data

22. Supplementary Tables 1-4 from Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

23. Data from Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

24. Supplementary Tables 1-9 from Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

25. Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAness

26. Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas

27. Quality of Life and Symptom Burden of Patients with MPN during Treatment with Hydroxyurea or Pegylated Interferon-alpha2: Results from a Randomized Controlled Trial

31. Whole blood transcriptional profiling reveals highly deregulated atherosclerosis genes in Philadelphia-chromosome negative myeloproliferative neoplasms.

33. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

38. Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat

39. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

40. The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium

43. Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAness.

48. Classification of Breast Cancer Subtypes by combining Gene Expression and DNA Methylation Data

50. A Signature of Exaggerated Adipose Tissue Dysfunction in Type 2 Diabetes Is Linked to Low Plasma Adiponectin and Increased Transcriptional Activation of Proteasomal Degradation in Muscle

Catalog

Books, media, physical & digital resources